Skip to main content

Advertisement

SpringerLink
Log in

Peyronie’s disease: Advances in basic science and pathophysiology

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Peyronie’s disease is an idiopathic, localized connective tissue disorder of the penis that involves the tunica albuginea of the corpus cavernosum and the adjacent areolar space. The tunica albuginea plays an important role in the mechanism of erection. Peyronie’s disease is characterized by local changes in the collagen and elastic fiber composition of the tunica albuginea. The formation of fibrotic plaques alters penile anatomy and can cause different degrees of bending, narrowing, or shortening of the penis. Moreover, a significant number of men with Peyronie’s disease develop erectile dysfunction. Penile blood flow studies in many patients with Peyronie’s disease suggest a strong association with veno-occlusive dysfunction. Although long recognized as an important clinical entity of the male genitalia, the etiology of this disease has remained poorly understood. The following review focuses on recent research on the pathophysiology of Peyronie’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Carson CC: Peyronie’s disease: medical and surgical management. In Handbook of Sexual Dysfunction. Edited by Hellstrom WJG. San Francisco: American Society of Andrology; 1999:93–98. This is an excellent review of the pathophysiology of Peyronie’s disease and the medical and surgical modalities used for the treatment of this disease process.

    Google Scholar 

  2. Gelbard MK, Dorey F, James K: The natural history of Peyronie’s disease. J Urol 1990, 144:1376–1380.

    PubMed  CAS  Google Scholar 

  3. Schwarzer U, Klotz T, Braun M, et al.: Prevalence of Peyronie’s disease—results of an 8,000 men survey. J Urol 2000, 163 (suppl):A742.

    Google Scholar 

  4. Carson CC: Francois Gigot de la Peyronie. Invest Urol 1981, 19:62–63.

    PubMed  CAS  Google Scholar 

  5. Lindsay MB, Schain DM, Grambsch P, et al.: The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991, 146:1007–1009.

    PubMed  CAS  Google Scholar 

  6. Scardino PL, Scott WW: The use of tocopherols in the treatment of Peyronie’s disease. Ann NY Acad Sci 1949, 52:390–401.

    Article  Google Scholar 

  7. Yudkin JS: Peyronie’s disease in association with metoprolol. Lancet 1977, 2:1355.

    Article  PubMed  CAS  Google Scholar 

  8. Vande Berg JS, Devine CJ, Horton CE, et al.: Mechanisms in calcification in Peyronie’s disease. J Urol 1982, 127:52–56.

    Google Scholar 

  9. Jarow JP, Lowe FC: Penile trauma: an etiologic factor in Peyronie’s disease and erectile dysfunction. J Urol 1997, 158:1388.

    Article  PubMed  CAS  Google Scholar 

  10. Somers KD, Winters PA, Dawson DM: Chromosomal abnormalities in Peyronie’s disease. J Urol 1987, 137:672–676.

    PubMed  CAS  Google Scholar 

  11. Nyberg LM, Bias WB, Hochberg MC: Identification of an inherited form of Peyronie’s disease with autosomal dominant inheritance and association with Dupuytren’s contracture and histocompatibility B7 cross-reacting antigens. J Urol 1982, 128:48–51.

    PubMed  Google Scholar 

  12. Chilton CP, Castle WM, Westwood CA, Pryor JP: Factors associated in the aetiology of Peyronie’s disease. Br J Urol 1982, 54:748–750.

    PubMed  CAS  Google Scholar 

  13. Levine LA, Merrick PF, Lee RC: Intralesional verapamil injection for the treatment of Peyronie’s disease. J Urol 1994, 151:1522–1524.

    PubMed  CAS  Google Scholar 

  14. Aboseif SR, Lue TF: Fundamentals and hemodynamics of penile erection. Cardiovasc Intervent Radiol 1988, 11:185–190.

    Article  PubMed  CAS  Google Scholar 

  15. Hsu GL, Brock G, von Heyden B, et al.: The distribution of elastic fibrous elements within the human penis. Br J Urol 1994, 37:566–571.

    Google Scholar 

  16. NIH Consensus Conference: Impotence. NIH Consensus Development Panel of Impotence. JAMA 1993, 270:83–90.

  17. Feldman HA, Goldstein I, Hatzichristou DG: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994, 151:54–61.

    PubMed  CAS  Google Scholar 

  18. Devine CJ, Somers KD, Ladaga LE: Peyronie’s disease: pathophysiology. Prog Clin Biol Res 1991, 370:355–358.

    PubMed  Google Scholar 

  19. Diegelmann RF: Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol 1997, 157:298–302. This is an exceptional review of the molecular and biochemical aspects of Peyronie’s disease and Dupuytren’s contracture. It evaluates the wound healing process after an injury to normal tissue.

    Article  PubMed  CAS  Google Scholar 

  20. Vande Berg JS, Device CJ, Horton CE, et al.: Peyronie’s disease: an electron micrographic study. J Urol 1981, 126:333–336.

    Google Scholar 

  21. Somers KD, Sismour EN, Wright GL: Isolation and characterization of collagen in Peyronie’s disease. J Urol 1989, 141:629–635.

    PubMed  CAS  Google Scholar 

  22. Luangkhot R, Rutchik S, Agarwal V, et al.: Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol 1992, 146:467–471.

    Google Scholar 

  23. Mersdorf A, Goldsmith PC, Diedrichs W: Ultrastructural changes in impotent penile tissue comparison of 65 patients. J Urol 1991, 145:749–754.

    PubMed  CAS  Google Scholar 

  24. Chiang PH, Chiang CP, Shen MR, et al.: Study of the changes in collagen of the tunica albuginea in venogenic impotence in Peyronie’s disease. Eur Urol 1992, 21:48–51.

    PubMed  CAS  Google Scholar 

  25. Iacono F, Barra S, DeRosa G, et al.: Microstructural disorders of the tunica albuginea in patients affected by Peyronie’s disease with or without erectile dysfunction. J Urol 1993, 150:1806–1809.

    PubMed  CAS  Google Scholar 

  26. Stewart S, Malto M, Sandberg L, Colburn KK: Increased serum levels of antielastin antibodies in patients with Peyronie’s disease. J Urol 1994, 152:105–106.

    PubMed  CAS  Google Scholar 

  27. Somers KD, Dawson DM, Wright GL Jr., et al.: Cell culture of Peyronie’s disease plaque and normal penile tissue. J Urol 1982, 127:585–588.

    PubMed  CAS  Google Scholar 

  28. Hirano D, Takimoto Y, Tamamoto T, et al.: Electron microscopic study of the penile plaques and adjacent corpora cavernosa in Peyronie’s disease. Int J Urol 1997, 4:274–278.

    PubMed  CAS  Google Scholar 

  29. Nicholson BE, Paloyan E, Vincent Shankey T, et al.: Peyronie’s disease fibroblasts fail to express telomerase. J Urol 1999, 161:783A.

    Article  Google Scholar 

  30. Delanty N, Dichter MA: Oxidative injury in the nervous system. Acta Neurol Scand 1998, 98:145–153.

    Article  PubMed  CAS  Google Scholar 

  31. Schellenberg KA, Shaeffer K, Yu J, Latannzio FA: Involvement of free radicals in tissue injury of Peyronie’s disease: mechanisms and possible therapeutic approaches. International Conference on Peyronie’s Disease: Advances in Basic and Clinical Research, March 17–19, 1993. National Institute of Digestive, Diabetes and Kidney Disorders of the National Institutes of Health, and the Devine Center for Genitourinary Reconstruction at Sentara Norfolk General Hospital.

  32. Ahuja SK, Sikka SC, Hellstrom WJG: Stimulation of collagen production in an in vivo model for Peyronie’s disease. Int J Impot Res 1999, 11:1–6.

    Article  Google Scholar 

  33. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286–1292.

    Article  PubMed  CAS  Google Scholar 

  34. Zhang K, Phan SH: Cytokines and pulmonary fibrosis. Biol Signals 1996, 5:232–239.

    PubMed  CAS  Google Scholar 

  35. El-Sakka AI, Hassoba HM, Pillarisetty RJ, et al.: Peyronie’s disease is associated with an increase in transforming growth factor-β protein expression. J Urol 1997, 158:1391–1396.

    Article  PubMed  CAS  Google Scholar 

  36. Moreland RB, Traish A, McMillin MA, et al.: PGE1 suppresses the induction of collagen synthesis by transforming growth factor-β in human corpus cavernosum smooth muscle. J Urol 1995, 153:826–834.

    Article  PubMed  CAS  Google Scholar 

  37. El-Sakka AI, Hassoba HM, Chui RM, et al.: An animal model of Peyronie’s like condition associated with an increase of transforming growth factor-β mRNA and protein expression. J Urol 1997, 158:2284–2290. This is the first study to establish an animal model of Peyronie’s disease.

    Article  PubMed  CAS  Google Scholar 

  38. El-Sakka AI, Selph CA, Yen TS, et al.: The effect of surgical trauma on rat tunica albuginea. J Urol 1998, 159:1700–1707.

    Article  PubMed  CAS  Google Scholar 

  39. Bivalacqua TJ, Purohit S, Sresthadatta A, et al.: Potential role of nuclear factor-κB in the induction of Peyronie’s-like condition in the rat. J Urol 1999, 161:781A.

    Google Scholar 

  40. Purohit SK, Bivalacqua TJ, Minor LC, et al.: Increased collagen type I and III fibers in the Peyronie’s disease rat model. J Urol 1999, 161:838A.

    Google Scholar 

  41. Burnett AL, Lowenstein CJ, Bredt DS, et al.: Nitric oxide: a physiologic mediator of penile erection. Science 1992, 257:401.

    Article  PubMed  CAS  Google Scholar 

  42. Burnett AL: Nitric oxide in the penis: physiology and pathology. J Urol 1997, 157:320.

    Article  PubMed  CAS  Google Scholar 

  43. Rajasekaran M, Mondal D, Agrawal K, et al.: Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998, 160:2210.

    Article  PubMed  CAS  Google Scholar 

  44. Seftel AD, Vaziri ND, Ni Z, et al.: Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997, 50:1016.

    Article  PubMed  CAS  Google Scholar 

  45. Bivalacqua TJ, Diner EK, Novak TE, et al.: A rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol 2000, 163:1992–1998. This study documents an association between inducible nitric oxide synthase and a decrease in erectile function in Peyronie’s disease.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Tulane University School of Medicine, 1430 Tulane Avenue, 70112, New Orleans, LA, USA

    Trinity J. Bivalacqua BS, Sunil K. Purohit MD & Wayne J. G. Hellstrom MD, FACS

Authors
  1. Trinity J. Bivalacqua BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunil K. Purohit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wayne J. G. Hellstrom MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bivalacqua, T.J., Purohit, S.K. & Hellstrom, W.J.G. Peyronie’s disease: Advances in basic science and pathophysiology. Curr Urol Rep 1, 297–301 (2000). https://doi.org/10.1007/s11934-000-0010-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-000-0010-8

Keywords

Search

Navigation